Loading clinical trials...
Loading clinical trials...
Subjective cognitive decline (SCD) is considered a preclinical condition associated with an increased risk of dementia and Alzheimer's disease. Effective early behavioral interventions remain limited,...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
China Medical University Hospital
NCT07457138 · Subjective Cognitive Decline (SCD), Functional Cognitive Disorder, and more
NCT07286448 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT07212504 · Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD)
NCT06095063 · Alzheimer Disease, Subjective Cognitive Decline
NCT06403345 · Mild Cognitive Impairment, Alzheimer Disease, and more
China Medical University Hospital
Taichung
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions